- Corporate Officers - P
- Pascoe Richard W
Insider Trading History of Pascoe Richard W
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pascoe Richard W since 2010.
This trader's CIK number is 1343266.
At the time of last reporting, Pascoe Richard W was the Chief Executive Officer of Zevra Therapeutics, Inc.. (stock ticker symbol ZVRA).
Also see all insider trading activities at Zevra Therapeutics, Inc..
Note that in the past
Pascoe Richard W also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Histogen Inc. (HSTO) by Pascoe Richard W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | HSTO | 20,000 | $22,799 | 0 | $0 | 0 | $0 |
| 2020 | HSTO | 10,000 | $12,390 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Zevra Therapeutics, Inc. (ZVRA) by Pascoe Richard W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | ZVRA | 19,500 | $93,660 | 0 | $0 | 0 | $0 |
| 2022 | ZVRA | 5,000 | $24,580 | 0 | $0 | 0 | $0 |
| 2021 | ZVRA | 1,500 | $11,821 | 0 | $0 | 0 | $0 |
| 2020 | ZVRA | 10,000 | $6,360 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Somaxon Pharmaceuticals, Inc. (SOMX) by Pascoe Richard W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | SOMX | 0 | $0 | 18,750 | $8,943 | 0 | $0 |
| 2011 | SOMX | 11,100 | $24,941 | 0 | $0 | 0 | $0 |
| 2010 | SOMX | 0 | $0 | 228,291 | $1,166,814 | 190,000 | $233,700 |
Yearly summary of insider trading at Seelos Therapeutics, Inc. (APRI) by Pascoe Richard W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | APRI | 22,000 | $28,340 | 0 | $0 | 0 | $0 |
| 2013 | APRI | 35,000 | $99,750 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Pascoe Richard W:
1. Histogen Inc. (HSTO)
2. Zevra Therapeutics, Inc. (ZVRA)
3. Somaxon Pharmaceuticals, Inc. (SOMX)
4. Seelos Therapeutics, Inc. (APRI)
Table 1. Insider trading of Histogen Inc. (HSTO) by Pascoe Richard W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-03-30 | HSTO | Buy | 20,000 | 1.14 | 22,799 |
| 2020-12-03 | HSTO | Buy | 10,000 | 1.24 | 12,390 |
Table 2. Insider trading of Zevra Therapeutics, Inc. (ZVRA) by Pascoe Richard W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-03-09 | ZVRA | Buy | 10,000 | 4.20 | 41,980 |
| 2023-01-13 | KMPH | Buy | 9,500 | 5.44 | 51,680 |
| 2022-05-18 | KMPH | Buy | 5,000 | 4.92 | 24,580 |
| 2021-11-30 | KMPH | Buy | 1,500 | 7.88 | 11,821 |
| 2020-08-18 | KMPH | Buy | 10,000 | .64 | 6,360 |
Table 3. Insider trading of Somaxon Pharmaceuticals, Inc. (SOMX) by Pascoe Richard W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-01-03 | SOMX | Sale | 18,750 | .48 | 8,943 |
| 2011-06-10 | SOMX | Buy | 11,100 | 2.25 | 24,941 |
| 2010-12-01 | SOMX | Sale | 13,781 | 2.68 | 36,974 |
| 2010-03-18 | SOMX | Option Ex | 100,000 | 1.23 | 123,000 |
| 2010-03-18 | SOMX | Sale | 104,510 | 7.40 | 773,164 |
| 2010-03-01 | SOMX | Sale | 40,000 | 4.01 | 160,520 |
| 2010-03-01 | SOMX | Option Ex | 40,000 | 1.23 | 49,200 |
| 2010-02-05 | SOMX | Option Ex | 50,000 | 1.23 | 61,500 |
| 2010-02-05 | SOMX | Sale | 62,000 | 3.03 | 187,612 |
| 2009-12-31 | SOMX | Sale | 8,000 | 1.07 | 8,544 |
Table 4. Insider trading of Seelos Therapeutics, Inc. (APRI) by Pascoe Richard W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-12-22 | APRI | Buy | 10,000 | 1.02 | 10,220 |
| 2014-10-22 | APRI | Buy | 12,000 | 1.51 | 18,120 |
| 2013-05-23 | APRI | Buy | 35,000 | 2.85 | 99,750 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pascoe Richard W
(Chief Executive Officer of Zevra Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.